BioCentury | May 25, 2015
Financial News

Nanosphere completes debt financing

...Diagnostic Date completed: 2015-05-15 Type: Debt financing Raised: $20 million Investors: Life Sciences Alternative Funding; SWK Funding LLC...
BioCentury | Aug 18, 2014
Financial News

Response Genetics completes debt financing

...Angeles, Calif. Business: Pharmacogenetics, Diagnostic Date completed: 2014-08-05 Type: Debt financing Raised: $8.5 million Investor: SWK Funding LLC...
BioCentury | Feb 10, 2014
Company News

InSite, Bess Royalty, SWK Holdings deal

...InSite said it received a $1 million milestone payment from Bess Royalty and the SWK Funding LLC subsidiary...
BioCentury | Apr 8, 2013
Company News

InSite, Bausch + Lomb, Bess Royalty, SWK Holdings deal

...sold its royalty on sales of Besivance besifloxacin ophthalmic solution to Bess Royalty and the SWK Funding LLC...
Items per page:
1 - 4 of 4
BioCentury | May 25, 2015
Financial News

Nanosphere completes debt financing

...Diagnostic Date completed: 2015-05-15 Type: Debt financing Raised: $20 million Investors: Life Sciences Alternative Funding; SWK Funding LLC...
BioCentury | Aug 18, 2014
Financial News

Response Genetics completes debt financing

...Angeles, Calif. Business: Pharmacogenetics, Diagnostic Date completed: 2014-08-05 Type: Debt financing Raised: $8.5 million Investor: SWK Funding LLC...
BioCentury | Feb 10, 2014
Company News

InSite, Bess Royalty, SWK Holdings deal

...InSite said it received a $1 million milestone payment from Bess Royalty and the SWK Funding LLC subsidiary...
BioCentury | Apr 8, 2013
Company News

InSite, Bausch + Lomb, Bess Royalty, SWK Holdings deal

...sold its royalty on sales of Besivance besifloxacin ophthalmic solution to Bess Royalty and the SWK Funding LLC...
Items per page:
1 - 4 of 4